{
  "docId": "019de071-eb84-776b-8e7d-ce40a476afec",
  "docSlug": "ee62a94395a2a2b10c5eb93465b3bf02",
  "documentTitle": "Kymera | Investor Day Presentation Deck | 105 slides",
  "authorId": "kymera",
  "authorName": "Kymera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 63,
  "pageCount": 105,
  "prevPage": 62,
  "nextPage": 64,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 12,
  "notes": "Includes box plots for gene expression and tumor volume growth curves, plus a Kaplan-Meier survival curve.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-eb84-776b-8e7d-ce40a476afec/63",
  "deckHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec",
  "deckJsonHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec.json",
  "deckAnchorHref": "/decks/019de071-eb84-776b-8e7d-ce40a476afec#slide-63",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.25,
        "x": 0.22,
        "y": 0.52
      },
      "kind": "chart",
      "text": "IFN-y and Expanded Immune Gene Signature",
      "attrs": null,
      "subkind": "box",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0966658e-a8ff-44c9-ad2a-97b13c142e96",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.46,
        "x": 0.04,
        "y": 0.25
      },
      "kind": "chart",
      "text": "IFN-dependent Gene Signature Induced by STAT3 Degrader Monotherapy in CT-26 Tumors",
      "attrs": null,
      "subkind": "box",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5fb7e1a9-5d56-4c2c-86ef-7b2a9ed3ac5e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.33,
        "x": 0.65,
        "y": 0.22
      },
      "kind": "chart",
      "text": "Tumor Volume and Survival Curves",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3b2a05c2-fefd-4d83-92c1-f5184226a788",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.13,
        "x": 0.5,
        "y": 0.25
      },
      "kind": "list",
      "text": "KTX-201 synergizes with anti-PD-1 leading to 60% complete responses in CT-26 model. Complete responders reject tumor rechallenge demonstrating development of long-term immune memory. Combination extends survival.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8902792c-c400-4364-bfd9-c72345ede305",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.18,
        "x": 0.03,
        "y": 0.535
      },
      "kind": "list",
      "text": "STAT3 degradation remodels the CT-26 TME to be more immune-favorable with upregulation of anti-tumor immunity genes previously identified as predictors of clinical response to pembrolizumab",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f8b11b29-b905-4f8e-8546-bfdf8cd0bc4b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.64,
        "x": 0.18,
        "y": 0.03
      },
      "kind": "title",
      "text": "STAT3 Degrader's Role in Immuno-Oncology: Sensitization of Tumors to Anti PD-1",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2b107ccb-6fff-4804-9852-5f79da893bbe",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Before-After-Bridge",
      "slug": "before-after-bridge",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "1a9d3d29-51d2-466e-8d75-35b4336f2d78",
      "evidence": "The slide shows the effect of STAT3 degrader on tumors with and without anti-PD-1 treatment.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}